-- Adolor, Banner, Fannie Mae, Kaman, Lincare, Walgreen: U.S. Equity Movers
-- Kelly Bit
-- 2010-06-18T20:44:33Z
-- http://www.bloomberg.com/news/2010-06-17/adolor-kaman-smart-modular-tutor-perini-u-s-equity-preview.html

          
          
             Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 4 p.m. in New York.  
 Adolor Corp.  (ADLR US) fell 8.7 percent to $1.37, the
lowest price since Dec. 16. The biopharmaceutical company said
two drugs it’s developing with Pfizer Inc. (PFE US) were no more
effective than a placebo at controlling pain from
osteoarthritis.  
 Amylin Pharmaceuticals Inc.  (AMLN US) jumped the most in
the Russell 1000 Index, rallying 20 percent to $19.80. Roche
Holding AG (ROG VX) delayed development of the experimental
diabetes drug taspoglutide, which competes with Amylin’s Byetta.
JPMorgan Chase & Co. upgraded Amylin to “overweight” from
“neutral.”  
 Alkermes Inc.  (ALKS US), which is developing a once-weekly
version of the Type 2 diabetes drug Byetta with Amylin, climbed
9.4 percent to $12.65.  
 Banner Corp.  (BANR US) dropped 24 percent, the most since
Jan. 29, to $2.70. The Walla Walla, Washington-based bank
holding company is offering $150 million of shares, according to
a regulatory filing.  
 Covanta Holding Corp.  (CVA US) jumped 11 percent, the most
since November 2008, to $18.62. The developer of waste-to-energy
plants declared a special cash dividend of $1.50 per share and
said its board authorized a buyback of as much as $150 million
of stock.  
 Freddie Mac  (FRE US) fell 22 percent to 40 cents and  Fannie
Mae  (FNM US) dropped 18 percent to 35 cents. Federal Deposit
Insurance Corp. Chairman  Sheila Bair  said an overhaul of the
mortgage firms 80 percent owned by the federal government
“should rise to the top of the agenda” as soon as Congress
finishes its rewrite of financial-industry rules.  
 General Maritime Corp.  (GMR US) fell 4.4 percent to $6.76,
the lowest price since June 8. The oil tanker owner said
yesterday it would price its offering of 30.6 million shares at
$6.75 a share.  
 HCP Inc.  (HCP US) fell the most in the Standard & Poor’s
500 Index, dropping 4.8 percent to $32.72. The health-care real
estate investment trust said it priced 13.5 million shares at
$33 each, boosting the offering from previously announced 12
million shares.  
 Kaman Corp.  (KAMN US) lost 5 percent, the most since May
20, to $23.53. The Connecticut-based aerospace company cut its
forecast because of shipping delays. Second-quarter profit will
be 20 cents a share at most, Kaman said. That trailed the 39-
cent average estimate from analysts in a Bloomberg survey.  
 Lincare Holdings Inc.  (LNCR US) decreased 5.5 percent, the
most since May 5, to $30.50. The provider of oxygen services for
patients at home was cut to “hold” from “buy” at Jefferies &
Co. Inc.  
 Motricity Inc.  (MOTR US) fell 7.4 percent to $9.26 on its
first day of trading. The company, which sells software to
mobile-phone companies that lets users access the Internet, sold
5 million shares at $10 each in an initial public offering.  
 Smart Modular Technologies Inc.  (SMOD US) gained 3.5
percent to $6.73, the lower price since May 13. The storage
chipmaker forecast fourth-quarter sales of at least $200
million, beating the average analyst estimate of $186.4 million.  
 Walgreen Co.  (WAG US) rose 2.8 percent, the most since Dec.
9, to $30.09. The company and  CVS Caremark Corp.  (CVS US), the
largest U.S. drugstore chains, agreed to allow pharmacy-benefits
customers to keep filling prescriptions at Walgreen’s locations,
ending an 11-day dispute. CVS advanced 1.9 percent to $32.43.  
 Their rivals declined.  Express Scripts Inc.  (ESRX US) fell
1.4 percent to $52.02.  Medco Health Solutions Inc.  (MHS US)
slipped 2.4 percent to $60.05.  
 Wimm-Bill-Dann Foods  (WBD US) slumped 9.1 percent, the most
since May 26, to $19.61. Russia’s largest dairy producer would
be prepared to buy back Danone SA’s (BN FP) stake in the company
if it became available, board member  David Yakobashvili  said.  
 To contact the reporter on this story:
 Kelly Bit  in New York at   kbit@bloomberg.net   
          
          


  


        